![](https://images.squarespace-cdn.com/content/v1/656f1b3c477a170db862490c/107fee26-25cd-459d-9374-9175b43a9156/canyon-1740973%281%29-min.jpg)
Investment Support
Investment Analysis & In-Licensing
The performance of investment funds, company builders, and similar entities depends on the identification of investment opportunities with a high return on investment. We collaborate with such organizations to scope and select companies or assets that have the potential to revolutionize the industry. We analyze assets individually, manage entire portfolios, or help clients achieve the best possible exit. For pharmaceutical or larger biotech companies, we help select the most promising assets to license in. Given our large number of collaborations in the past and present, we are both highly experienced and quick at making these assessments.
![](https://images.squarespace-cdn.com/content/v1/656f1b3c477a170db862490c/142404a9-1806-4056-8d6a-3292715c5ac3/pawel-czerwinski-X4PSwltIx9c-unsplash.jpg)
Portfolio Management
THE TEXT IS MISSING RIGHT NOW
Primary Market Research
A major challenge for innovative first-in-class drugs, novel medical devices or diagnostics, and new treatment regimens is the uncertainty regarding the potential market uptake and pricing/reimbursement. We offer primary market research, including interviews with key opinion leaders and payor organizations in all countries. All interviews with medical personnel are conducted by our medical doctors. Our interviews as well as all market research may be performed in English, German, Spanish, or Italian. For other languages, we cooperate with local organizations. The output of our market research provides you with valuable information regarding an asset’s pricing, reimbursement, delivery, and expected market share. The market and patient environment can vary highly between countries, even within Europe.
Competitive Intelligence
We have collaborated with many of the world’s most innovative life sciences companies and maintain close connections with leading academic institutions. In addition, we have access to all major industry-relevant databases. This puts us in an enviable position when it comes to Competitive Intelligence. We can analyze the competitive landscape for technologies, targets, indications, and patient subpopulations – both from a macro-perspective (trends) and on a micro level in every detail. This helps you avoid competitors or adapt your marketing strategy.
International Product Adaptation
Health systems vary considerably across the globe. Even within Europe, they are highly heterogeneous concerning patient flow, insurance coverage, and even medical disciplines. We help you tailor your product to the health systems of the world. This may be of particular interest for non-conventional products, such as niche medical devices or complex treatment regimens.